share_log

We Like The Quality Of LifeTech Scientific's (HKG:1302) Earnings

We Like The Quality Of LifeTech Scientific's (HKG:1302) Earnings

我们喜欢 LifeTech Scientific(HKG: 1302)收益的质量
Simply Wall St ·  2022/04/29 06:23

The market seemed underwhelmed by last week's earnings announcement from LifeTech Scientific Corporation (HKG:1302) despite the healthy numbers. We did some digging, and we think that investors are missing some encouraging factors in the underlying numbers.

上周公布的财报似乎让市场不知所措 LifeTech科学公司 (HKG: 1302)尽管数字不错。我们做了一些挖掘,我们认为投资者在基础数字中遗漏了一些令人鼓舞的因素。

View our latest analysis for LifeTech Scientific

查看我们对LifeTech科学的最新分析

SEHK:1302 Earnings and Revenue History April 28th 2022
SEHK: 1302 收益和收入记录 2022 年 4 月 28 日

The Impact Of Unusual Items On Profit

不寻常物品对利润的影响

Importantly, our data indicates that LifeTech Scientific's profit was reduced by CN¥51m, due to unusual items, over the last year. It's never great to see unusual items costing the company profits, but on the upside, things might improve sooner rather than later. We looked at thousands of listed companies and found that unusual items are very often one-off in nature. And that's hardly a surprise given these line items are considered unusual. Assuming those unusual expenses don't come up again, we'd therefore expect LifeTech Scientific to produce a higher profit next year, all else being equal.

重要的是,我们的数据表明,由于异常项目,LifeTech Scientific的利润比去年减少了5100万人民币。看到不寻常的物品使公司损失利润从来都不是一件好事,但从好的方面来看,情况迟早会好转。我们调查了成千上万的上市公司,发现不寻常的物品本质上通常是一次性的。鉴于这些单列项目被认为不寻常,这并不奇怪。假设这些不寻常的支出不会再次出现,因此,在其他条件相同的情况下,我们预计LifeTech Scientific明年将产生更高的利润。

Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of LifeTech Scientific.

注意: 我们始终建议投资者检查资产负债表的强度。点击此处查看我们对LifeTech Scientific的资产负债表分析。

Our Take On LifeTech Scientific's Profit Performance

我们对LifeTech Scientific盈利表现

Unusual items (expenses) detracted from LifeTech Scientific's earnings over the last year, but we might see an improvement next year. Because of this, we think LifeTech Scientific's earnings potential is at least as good as it seems, and maybe even better! And on top of that, its earnings per share have grown at an extremely impressive rate over the last three years. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. If you'd like to know more about LifeTech Scientific as a business, it's important to be aware of any risks it's facing. Every company has risks, and we've spotted 1 warning sign for LifeTech Scientific you should know about.

去年,不寻常的项目(开支)减少了LifeTech Scientific的收益,但我们可能会看到明年有所改善。因此,我们认为LifeTech Scientific的盈利潜力至少和看起来一样好,甚至可能更好!最重要的是,在过去三年中,其每股收益以极其惊人的速度增长。当然,在分析其收益时,我们只是浮出水面;人们还可以考虑利润率、预测增长和投资回报率等因素。如果您想进一步了解LifeTech Scientific作为一家企业,了解其面临的任何风险很重要。每家公司都有风险,我们发现了一个你应该知道的LifeTech Scientific的警告信号。

Today we've zoomed in on a single data point to better understand the nature of LifeTech Scientific's profit. But there are plenty of other ways to inform your opinion of a company. Some people consider a high return on equity to be a good sign of a quality business. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying.

今天,我们放大了单个数据点,以更好地了解LifeTech Scientific的利润性质。但是还有很多其他方法可以告诉你对公司的看法。有些人认为高股本回报率是优质业务的好兆头。所以你可能希望看到这个 免费的 一系列拥有高股本回报率的公司,或者这份内部人士正在买入的股票清单。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?担心内容吗? 取得联系 直接和我们在一起。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St 的这篇文章本质上是笼统的。 我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。 它不构成买入或卖出任何股票的建议,也没有考虑您的目标或财务状况。我们的目标是为您提供由基本面数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。简而言之,华尔街在上述任何股票中都没有头寸。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发